Published in Crit Rev Biochem Mol Biol on June 07, 2012
Study of Ataluren (PTC124™) in Cystic Fibrosis | NCT00803205
Study of Ataluren for Previously Treated Patients With nmDBMD in the US | NCT01247207
Ribosome. The structure of the human mitochondrial ribosome. Science (2015) 1.82
Attenuation of nonsense-mediated mRNA decay enhances in vivo nonsense suppression. PLoS One (2013) 1.11
Nonsense-mediated decay in genetic disease: friend or foe? Mutat Res Rev Mutat Res (2014) 1.10
Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor. Am J Respir Cell Mol Biol (2014) 1.10
Designer aminoglycosides that selectively inhibit cytoplasmic rather than mitochondrial ribosomes show decreased ototoxicity: a strategy for the treatment of genetic diseases. J Biol Chem (2013) 1.01
Mechanism and regulation of the nonsense-mediated decay pathway. Nucleic Acids Res (2016) 0.99
Postnatal manipulation of Pax6 dosage reverses congenital tissue malformation defects. J Clin Invest (2013) 0.94
Translational read-through of the RP2 Arg120stop mutation in patient iPSC-derived retinal pigment epithelium cells. Hum Mol Genet (2014) 0.92
5-azacytidine inhibits nonsense-mediated decay in a MYC-dependent fashion. EMBO Mol Med (2014) 0.91
Identification of the molecular attributes required for aminoglycoside activity against Leishmania. Proc Natl Acad Sci U S A (2013) 0.85
Rett syndrome like phenotypes in the R255X Mecp2 mutant mouse are rescued by MECP2 transgene. Hum Mol Genet (2015) 0.84
When Proteins Start to Make Sense: Fine-tuning Aminoglycosides for PTC Suppression Therapy. Medchemcomm (2014) 0.83
Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations. Am J Respir Crit Care Med (2016) 0.82
The unfolded protein response affects readthrough of premature termination codons. EMBO Mol Med (2014) 0.82
Cryptic MHC class I-binding peptides are revealed by aminoglycoside-induced stop codon read-through into the 3' UTR. Proc Natl Acad Sci U S A (2014) 0.80
Synthesis and activity of a novel inhibitor of nonsense-mediated mRNA decay. Org Biomol Chem (2016) 0.77
Global and disease-associated genetic variation in the human Fanconi anemia gene family. Hum Mol Genet (2014) 0.76
Rescue of the MERTK phagocytic defect in a human iPSC disease model using translational read-through inducing drugs. Sci Rep (2017) 0.75
Generating SM(a)RTer compounds for translation termination suppression in A-T and other genetic disorders. Mol Ther (2013) 0.75
In Silico Analysis of the Structural and Biochemical Features of the NMD Factor UPF1 in Ustilago maydis. PLoS One (2016) 0.75
Chemical-Induced Read-Through at Premature Termination Codons Determined by a Rapid Dual-Fluorescence System Based on S. cerevisiae. PLoS One (2016) 0.75
Current and Emerging Therapies for the Treatment of Cystic Fibrosis or Mitigation of Its Symptoms. Drugs R D (2016) 0.75
Efficacy of Postnatal In Vivo Nonsense Suppression Therapy in a Pax6 Mouse Model of Aniridia. Mol Ther Nucleic Acids (2017) 0.75
Recognition of cognate transfer RNA by the 30S ribosomal subunit. Science (2001) 8.68
The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science (1989) 6.80
PTC124 targets genetic disorders caused by nonsense mutations. Nature (2007) 6.67
An animal model for cystic fibrosis made by gene targeting. Science (1992) 5.75
Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. Proc Natl Acad Sci U S A (2009) 5.72
Selection of tRNA by the ribosome requires a transition from an open to a closed form. Cell (2002) 5.62
Binding of a novel SMG-1-Upf1-eRF1-eRF3 complex (SURF) to the exon junction complex triggers Upf1 phosphorylation and nonsense-mediated mRNA decay. Genes Dev (2006) 5.59
PHENOTYPIC REPAIR BY STREPTOMYCIN OF DEFECTIVE GENOTYPES IN E. COLI. Proc Natl Acad Sci U S A (1964) 5.43
Quality control of eukaryotic mRNA: safeguarding cells from abnormal mRNA function. Genes Dev (2007) 4.97
Errors and alternatives in reading the universal genetic code. Microbiol Rev (1989) 4.67
Transfer RNA shields specific nucleotides in 16S ribosomal RNA from attack by chemical probes. Cell (1986) 4.65
Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations. N Engl J Med (2003) 4.43
Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial. Lancet (2008) 4.35
A highly conserved eukaryotic protein family possessing properties of polypeptide chain release factor. Nature (1994) 4.21
Release factors differing in specificity for terminator codons. Proc Natl Acad Sci U S A (1968) 4.18
Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic. Science (1996) 3.94
Insights into translational termination from the structure of RF2 bound to the ribosome. Science (2008) 3.89
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. Proc Natl Acad Sci U S A (2011) 3.87
A faux 3'-UTR promotes aberrant termination and triggers nonsense-mediated mRNA decay. Nature (2004) 3.60
Phosphorylation of hUPF1 induces formation of mRNA surveillance complexes containing hSMG-5 and hSMG-7. Mol Cell (2003) 3.53
Structural basis for translation termination on the 70S ribosome. Nature (2008) 3.50
Pharmacology of gentamicin in man. J Infect Dis (1971) 3.16
Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest (1999) 3.06
The multiple lives of NMD factors: balancing roles in gene and genome regulation. Nat Rev Genet (2008) 3.00
The efficiency of translation termination is determined by a synergistic interplay between upstream and downstream sequences in Saccharomyces cerevisiae. J Mol Biol (1995) 2.97
Fidelity of aminoacyl-tRNA selection on the ribosome: kinetic and structural mechanisms. Annu Rev Biochem (2001) 2.97
The eukaryotic polypeptide chain releasing factor (eRF3/GSPT) carrying the translation termination signal to the 3'-Poly(A) tail of mRNA. Direct association of erf3/GSPT with polyadenylate-binding protein. J Biol Chem (1999) 2.74
In vitro reconstitution of eukaryotic translation reveals cooperativity between release factors eRF1 and eRF3. Cell (2006) 2.62
INTERACTION OF STREPTOMYCIN AND A SUPPRESSOR FOR GALACTOSE FERMENTATION IN E. COLI K-12. Proc Natl Acad Sci U S A (1964) 2.56
Translational termination efficiency in mammals is influenced by the base following the stop codon. Proc Natl Acad Sci U S A (1995) 2.49
Eukaryotic polypeptide chain release factor eRF3 is an eRF1- and ribosome-dependent guanosine triphosphatase. RNA (1996) 2.48
Aminoglycoside suppression of a premature stop mutation in a Cftr-/- mouse carrying a human CFTR-G542X transgene. J Mol Med (Berl) (2002) 2.34
New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view. Kidney Int (2010) 2.33
Crystal structure of a translation termination complex formed with release factor RF2. Proc Natl Acad Sci U S A (2008) 2.33
Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system. RNA (2000) 2.31
Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations. Ann Neurol (2001) 2.29
PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model. Proc Natl Acad Sci U S A (2008) 2.22
Sequence analysis suggests that tetra-nucleotides signal the termination of protein synthesis in eukaryotes. Nucleic Acids Res (1990) 2.20
Is there proofreading during polypeptide synthesis? EMBO J (1982) 2.18
Mechanism of PTC124 activity in cell-based luciferase assays of nonsense codon suppression. Proc Natl Acad Sci U S A (2009) 2.18
Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers. J Clin Pharmacol (2007) 2.16
Quality control by the ribosome following peptide bond formation. Nature (2008) 2.15
Proofreading of the codon-anticodon interaction on ribosomes. Proc Natl Acad Sci U S A (1977) 2.14
The role of ABCE1 in eukaryotic posttermination ribosomal recycling. Mol Cell (2010) 2.14
CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium. PLoS Biol (2009) 2.10
A posttermination ribosomal complex is the guanine nucleotide exchange factor for peptide release factor RF3. Cell (2001) 2.10
NMD: RNA biology meets human genetic medicine. Biochem J (2010) 2.09
Polypeptide chain termination in vitro: isolation of a release factor. Proc Natl Acad Sci U S A (1967) 2.08
Conformational switch in the decoding region of 16S rRNA during aminoacyl-tRNA selection on the ribosome. Nat Struct Biol (2000) 2.05
The accuracy of codon recognition by polypeptide release factors. Proc Natl Acad Sci U S A (2000) 2.03
Poly(A)-binding protein acts in translation termination via eukaryotic release factor 3 interaction and does not influence [PSI(+)] propagation. Mol Cell Biol (2002) 1.92
Basis for prokaryotic specificity of action of aminoglycoside antibiotics. EMBO J (1999) 1.91
GTP hydrolysis by eRF3 facilitates stop codon decoding during eukaryotic translation termination. Mol Cell Biol (2004) 1.87
Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy. Ann Neurol (2010) 1.81
Sequence of steps in ribosome recycling as defined by kinetic analysis. Mol Cell (2005) 1.78
Recognition and elimination of nonsense mRNA. Biochim Biophys Acta (2008) 1.74
Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin. J Clin Invest (2007) 1.73
Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis. Am J Respir Crit Care Med (2001) 1.72
Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis. Am J Respir Crit Care Med (2010) 1.71
Splitting of the posttermination ribosome into subunits by the concerted action of RRF and EF-G. Mol Cell (2005) 1.69
Introducing sense into nonsense in treatments of human genetic diseases. Trends Genet (2008) 1.69
The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I. Expert Opin Pharmacother (2005) 1.68
Hydrolysis of fMet-tRNA by peptidyl transferase. Proc Natl Acad Sci U S A (1971) 1.67
Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment. EMBO Rep (2004) 1.66
Discrimination between defects in elongation fidelity and termination efficiency provides mechanistic insights into translational readthrough. J Mol Biol (2005) 1.65
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis. Eur Respir J (2011) 1.63
The clinical outcome of Hurler syndrome after stem cell transplantation. Biol Blood Marrow Transplant (2008) 1.60
Aminoglycoside suppression at UAG, UAA and UGA codons in Escherichia coli and human tissue culture cells. Mol Gen Genet (1989) 1.59
Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin. Biochem Pharmacol (1982) 1.58
Polyaspartic acid prevents experimental aminoglycoside nephrotoxicity. J Infect Dis (1989) 1.57
A biochemical basis for the inherited susceptibility to aminoglycoside ototoxicity. Hum Mol Genet (2000) 1.56
Termination and post-termination events in eukaryotic translation. Adv Protein Chem Struct Biol (2012) 1.53
Development of novel aminoglycoside (NB54) with reduced toxicity and enhanced suppression of disease-causing premature stop mutations. J Med Chem (2009) 1.53
Nonsense-mediated mRNA decay (NMD) in animal embryogenesis: to die or not to die, that is the question. Curr Opin Genet Dev (2011) 1.52
TransTerm, the translational signal database, extended to include full coding sequences and untranslated regions. Nucleic Acids Res (1999) 1.52
Peptide release on the ribosome: mechanism and implications for translational control. Annu Rev Microbiol (2008) 1.48
Gentamicin administration in Duchenne patients with premature stop codon. Preliminary results. Acta Myol (2003) 1.48
Inhibition of nonsense-mediated mRNA decay (NMD) by a new chemical molecule reveals the dynamic of NMD factors in P-bodies. J Cell Biol (2007) 1.47
Premature translation termination mutations are efficiently suppressed in a highly conserved region of yeast Ste6p, a member of the ATP-binding cassette (ABC) transporter family. J Biol Chem (1994) 1.44
Readthrough of nonsense mutations in Rett syndrome: evaluation of novel aminoglycosides and generation of a new mouse model. J Mol Med (Berl) (2010) 1.40
Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections. J Antimicrob Chemother (2008) 1.37
A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations. Am J Respir Crit Care Med (2000) 1.37
UAG readthrough in mammalian cells: effect of upstream and downstream stop codon contexts reveal different signals. BMC Mol Biol (2001) 1.36
Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation. Hum Mol Genet (2001) 1.36
Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations. Bioorg Med Chem (2010) 1.35
Aminoglycoside induced ototoxicity. Toxicology (2008) 1.35
Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection. Int J Otolaryngol (2011) 1.32
Novel aminoglycosides increase SMN levels in spinal muscular atrophy fibroblasts. Hum Genet (2006) 1.31
Nonaminoglycoside compounds induce readthrough of nonsense mutations. J Exp Med (2009) 1.31
Ribosome structure and dynamics during translocation and termination. Annu Rev Biophys (2010) 1.31
Evolutionary optimization of speed and accuracy of decoding on the ribosome. Philos Trans R Soc Lond B Biol Sci (2011) 1.30
The role of ribosome recycling factor in dissociation of 70S ribosomes into subunits. RNA (2005) 1.29
Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model. J Mol Med (Berl) (2006) 1.28
Pharmacologic therapy for stop mutations: how much CFTR activity is enough? Curr Opin Pulm Med (2004) 1.28
A comprehensive analysis of translational missense errors in the yeast Saccharomyces cerevisiae. RNA (2010) 1.27
Eukaryotic ribosomal RNA determinants of aminoglycoside resistance and their role in translational fidelity. RNA (2007) 1.26
Distinct eRF3 requirements suggest alternate eRF1 conformations mediate peptide release during eukaryotic translation termination. Mol Cell (2008) 1.25
Recognition of the amber UAG stop codon by release factor RF1. EMBO J (2010) 1.23
Read-through strategies for suppression of nonsense mutations in Duchenne/ Becker muscular dystrophy: aminoglycosides and ataluren (PTC124). J Child Neurol (2010) 1.23
A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One (2010) 2.64
A semisynthetic epitope for kinase substrates. Nat Methods (2007) 2.40
The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation. Blood (2008) 2.35
Aminoglycoside suppression of a premature stop mutation in a Cftr-/- mouse carrying a human CFTR-G542X transgene. J Mol Med (Berl) (2002) 2.34
Genome-wide association identifies a susceptibility locus for coronary artery disease in the Chinese Han population. Nat Genet (2011) 2.32
Histone demethylase UTX-1 regulates C. elegans life span by targeting the insulin/IGF-1 signaling pathway. Cell Metab (2011) 2.22
PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model. Proc Natl Acad Sci U S A (2008) 2.22
A comparison of RNA-Seq and high-density exon array for detecting differential gene expression between closely related species. Nucleic Acids Res (2010) 2.07
Prkcz null mice show normal learning and memory. Nature (2013) 2.06
Leaky termination at premature stop codons antagonizes nonsense-mediated mRNA decay in S. cerevisiae. RNA (2004) 2.02
Burden of subclinical cardiovascular disease in "metabolically benign" and "at-risk" overweight and obese women: the Study of Women's Health Across the Nation (SWAN). Atherosclerosis (2011) 1.89
GTP hydrolysis by eRF3 facilitates stop codon decoding during eukaryotic translation termination. Mol Cell Biol (2004) 1.87
Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis. Nature (2005) 1.86
Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma. Clin Cancer Res (2011) 1.84
St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole. Clin Pharmacol Ther (2004) 1.79
Characterization of a novel influenza virus in cattle and Swine: proposal for a new genus in the Orthomyxoviridae family. MBio (2014) 1.75
Retracted Expression of microRNA-497 and its prognostic significance in human breast cancer. Diagn Pathol (2013) 1.70
Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus. Circulation (2011) 1.68
Discrimination between defects in elongation fidelity and termination efficiency provides mechanistic insights into translational readthrough. J Mol Biol (2005) 1.65
Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet (2012) 1.64
Comparative analyses of the three-dimensional structures and enzymatic properties of alpha, beta, gamma and delta isoforms of Ca2+-calmodulin-dependent protein kinase II. J Biol Chem (2004) 1.63
Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia. J Clin Oncol (2008) 1.63
Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function. PLoS Pathog (2009) 1.61
Number, density, and surface/cytoplasmic distribution of GABA transporters at presynaptic structures of knock-in mice carrying GABA transporter subtype 1-green fluorescent protein fusions. J Neurosci (2002) 1.58
Dynamic cervical plate versus static cervical plate in the anterior cervical discectomy and fusion: a systematic review. Eur J Orthop Surg Traumatol (2013) 1.54
Galectin-3 as a marker and potential therapeutic target in breast cancer. PLoS One (2014) 1.49
Characterizing breast cancer xenograft epidermal growth factor receptor expression by using near-infrared optical imaging. Acta Radiol (2009) 1.49
The Th17/Treg functional imbalance during atherogenesis in ApoE(-/-) mice. Cytokine (2009) 1.48
Baicalein selectively induces apoptosis in activated lymphocytes and ameliorates concanavalin a-induced hepatitis in mice. PLoS One (2013) 1.48
Molecular mechanisms involved in the growth stimulation of breast cancer cells by leptin. Cancer Res (2004) 1.47
Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis. J Am Soc Nephrol (2009) 1.45
Candidate pathway-based genome-wide association studies identify novel associations of genomic variants in the complement system associated with coronary artery disease. Circ Cardiovasc Genet (2014) 1.45
Coordinated regulation of AIB1 transcriptional activity by sumoylation and phosphorylation. J Biol Chem (2006) 1.43
Vascular invasion in hepatitis B virus-related hepatocellular carcinoma with underlying cirrhosis: possible associations with ascites and hepatitis B viral factors? Tumour Biol (2015) 1.43
Protein kinase C epsilon regulates gamma-aminobutyrate type A receptor sensitivity to ethanol and benzodiazepines through phosphorylation of gamma2 subunits. J Biol Chem (2007) 1.43
Plasminogen activator inhibitor-1 is a transcriptional target of the canonical pathway of Wnt/beta-catenin signaling. J Biol Chem (2010) 1.41
Differential gene regulation by the SRC family of coactivators. Genes Dev (2004) 1.41
Clinically relevant aminoglycosides can suppress disease-associated premature stop mutations in the IDUA and P53 cDNAs in a mammalian translation system. J Mol Med (Berl) (2002) 1.40
Dynamic postural stability in young adolescent male and female athletes. Pediatr Phys Ther (2014) 1.39
The CYP2C19 ultra-rapid metabolizer genotype influences the pharmacokinetics of voriconazole in healthy male volunteers. Eur J Clin Pharmacol (2008) 1.37
Conditional rescue of protein kinase C epsilon regulates ethanol preference and hypnotic sensitivity in adult mice. J Neurosci (2002) 1.35
Accurate control of multishelled ZnO hollow microspheres for dye-sensitized solar cells with high efficiency. Adv Mater (2012) 1.33
Protein kinase Cdelta regulates ethanol intoxication and enhancement of GABA-stimulated tonic current. J Neurosci (2008) 1.32
Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/β-catenin activity in CKD. J Am Soc Nephrol (2011) 1.32
Laparoscopic resection of presacral teratomas. J Minim Invasive Gynecol (2008) 1.30
Detection and characterization of influenza A virus PA-PB2 interaction through a bimolecular fluorescence complementation assay. J Virol (2009) 1.30
Human tumor microRNA signatures derived from large-scale oligonucleotide microarray datasets. Int J Cancer (2011) 1.29
Clinical doses of amikacin provide more effective suppression of the human CFTR-G542X stop mutation than gentamicin in a transgenic CF mouse model. J Mol Med (Berl) (2006) 1.28
General synthesis and gas-sensing properties of multiple-shell metal oxide hollow microspheres. Angew Chem Int Ed Engl (2011) 1.27
Eukaryotic ribosomal RNA determinants of aminoglycoside resistance and their role in translational fidelity. RNA (2007) 1.26
Assessment of association of rs2200733 on chromosome 4q25 with atrial fibrillation and ischemic stroke in a Chinese Han population. Hum Genet (2009) 1.25
Distinct eRF3 requirements suggest alternate eRF1 conformations mediate peptide release during eukaryotic translation termination. Mol Cell (2008) 1.25
Therapeutics based on stop codon readthrough. Annu Rev Genomics Hum Genet (2014) 1.23
Tpa1p is part of an mRNP complex that influences translation termination, mRNA deadenylation, and mRNA turnover in Saccharomyces cerevisiae. Mol Cell Biol (2006) 1.22
Aminoglycosides as potential pharmacogenetic agents in the treatment of Hailey-Hailey disease. J Invest Dermatol (2006) 1.22
Two-dimensional graphene bridges enhanced photoinduced charge transport in dye-sensitized solar cells. ACS Nano (2010) 1.21
Scavenger Receptor BI Protects against Septic Death through Its Role in Modulating Inflammatory Response. J Biol Chem (2009) 1.18
Cardiovascular disease risk of abdominal obesity vs. metabolic abnormalities. Obesity (Silver Spring) (2010) 1.18
Near-static dielectric polarization of individual carbon nanotubes. Nano Lett (2007) 1.16
Using 915 nm laser excited Tm³+/Er³+/Ho³+- doped NaYbF4 upconversion nanoparticles for in vitro and deeper in vivo bioimaging without overheating irradiation. ACS Nano (2011) 1.16
Hierarchically ordered macro-mesoporous TiO₂-graphene composite films: improved mass transfer, reduced charge recombination, and their enhanced photocatalytic activities. ACS Nano (2010) 1.16
Correlation between clinical outcome and growth factor pathway expression in osteogenic sarcoma. Cancer (2009) 1.14
Treatment factors affecting outcomes in HIV-associated non-Hodgkin lymphomas: a pooled analysis of 1546 patients. Blood (2013) 1.13
PDE4D and PDE4B function in distinct subcellular compartments in mouse embryonic fibroblasts. J Biol Chem (2011) 1.13
A novel, automated technology for multiplex biomarker imaging and application to breast cancer. Histopathology (2013) 1.12
Kinetics of calmodulin binding to calcineurin. Biochem Biophys Res Commun (2005) 1.12
Facile synthesis of surfactant-free Au cluster/graphene hybrids for high-performance oxygen reduction reaction. ACS Nano (2012) 1.12
Genomic and evolutionary characterization of a novel influenza-C-like virus from swine. Arch Virol (2013) 1.12
Nanog reverses the effects of organismal aging on mesenchymal stem cell proliferation and myogenic differentiation potential. Stem Cells (2012) 1.11
Attenuation of nonsense-mediated mRNA decay enhances in vivo nonsense suppression. PLoS One (2013) 1.11
Race-ethnic differences in adipokine levels: the Study of Women's Health Across the Nation (SWAN). Metabolism (2012) 1.11
Synthetic aminoglycosides efficiently suppress cystic fibrosis transmembrane conductance regulator nonsense mutations and are enhanced by ivacaftor. Am J Respir Cell Mol Biol (2014) 1.10
Nonsense suppression activity of PTC124 (ataluren). Proc Natl Acad Sci U S A (2009) 1.09
Identification of NPPA variants associated with atrial fibrillation in a Chinese GeneID population. Clin Chim Acta (2010) 1.09
Accurate control of multishelled Co3O4 hollow microspheres as high-performance anode materials in lithium-ion batteries. Angew Chem Int Ed Engl (2013) 1.09
Plasma membrane GABA transporters reside on distinct vesicles and undergo rapid regulated recycling. J Neurosci (2003) 1.08
Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. J Hepatol (2010) 1.08
Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases. Wiley Interdiscip Rev RNA (2011) 1.08
Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation. Br J Haematol (2009) 1.07
Highly efficient and completely flexible fiber-shaped dye-sensitized solar cell based on TiO2 nanotube array. Nanoscale (2012) 1.07
Designing an automated clinical decision support system to match clinical practice guidelines for opioid therapy for chronic pain. Implement Sci (2010) 1.06
DJ-1, a cancer and Parkinson's disease associated protein, regulates autophagy through JNK pathway in cancer cells. Cancer Lett (2010) 1.06
Multishelled TiO2 hollow microspheres as anodes with superior reversible capacity for lithium ion batteries. Nano Lett (2014) 1.06
Distinct paths to stop codon reassignment by the variant-code organisms Tetrahymena and Euplotes. Mol Cell Biol (2006) 1.05
Performance of forty-one microbial source tracking methods: a twenty-seven lab evaluation study. Water Res (2013) 1.05
Pollen semi-sterility1 encodes a kinesin-1-like protein important for male meiosis, anther dehiscence, and fertility in rice. Plant Cell (2011) 1.05
Evaluation of the acceptability and usability of a decision support system to encourage safe and effective use of opioid therapy for chronic, noncancer pain by primary care providers. Pain Med (2010) 1.04
Estrogen receptor α36 mediates a bone-sparing effect of 17β-estrodiol in postmenopausal women. J Bone Miner Res (2011) 1.04
Observation of multiphoton-induced fluorescence from graphene oxide nanoparticles and applications in in vivo functional bioimaging. Angew Chem Int Ed Engl (2012) 1.03
Minor allele C of chromosome 1p32 single nucleotide polymorphism rs11206510 confers risk of ischemic stroke in the Chinese Han population. Stroke (2010) 1.03
Quintuple-shelled SnO(2) hollow microspheres with superior light scattering for high-performance dye-sensitized solar cells. Adv Mater (2013) 1.03
PKCepsilon increases endothelin converting enzyme activity and reduces amyloid plaque pathology in transgenic mice. Proc Natl Acad Sci U S A (2006) 1.02
Enhancement of alveolar epithelial sodium channel activity with decreased cystic fibrosis transmembrane conductance regulator expression in mouse lung. Am J Physiol Lung Cell Mol Physiol (2011) 1.02
The outcome of laparoscopic radical hysterectomy and lymphadenectomy for cervical cancer: a prospective analysis of 295 patients. Ann Surg Oncol (2008) 1.02
Mechanism of TNF-α autocrine effects in hypoxic cardiomyocytes: initiated by hypoxia inducible factor 1α, presented by exosomes. J Mol Cell Cardiol (2012) 1.02
The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouse. Mol Genet Metab (2011) 1.01
A single polymorphism in HIV-1 subtype C SP1 is sufficient to confer natural resistance to the maturation inhibitor bevirimat. Antimicrob Agents Chemother (2011) 1.01
Mesenchymal nuclear factor I B regulates cell proliferation and epithelial differentiation during lung maturation. Dev Biol (2011) 1.01
Photosensitizer encapsulated organically modified silica nanoparticles for direct two-photon photodynamic therapy and in vivo functional imaging. Biomaterials (2012) 1.00